Prism Medico and Pharmacy Ltd - Stock Valuation and Financial Performance

BSE: 512217 | NSE: | Finance - Investment | Small Cap

Prism Medico Share Price

25.56 -1.49 -5.51%
as on 19-Mar'24 16:40

DeciZen - make an informed investing decision on Prism Medico

M-Cap below 100cr DeciZen not available

Prism Medico and Pharmacy stock performance -

mw4me loader
P/E Ratio (SA):
167.36
Market Cap:
16.4 Cr.
52-wk low:
22.4
52-wk high:
39.2

Is Prism Medico and Pharmacy Ltd an attractive stock to invest in?

1. Is Prism Medico and Pharmacy Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Prism Medico and Pharmacy Ltd is a below average quality company.

2. Is Prism Medico and Pharmacy Ltd undervalued or overvalued?

The key valuation ratios of Prism Medico and Pharmacy Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Prism Medico and Pharmacy Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Prism Medico and Pharmacy Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Prism Medico:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Prism Medico and Pharmacy Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Operating Income (₹ Cr.)000.10.12136.326.916.88.41.34
YoY Gr. Rt. %-NANA0%23188.9%73.2%-25.9%-37.7%-49.6%-85%-
Adj EPS (₹ ) -0.3-0.1-0-0.4-00.6-0.1-0.2-0.6-0.10.2
YoY Gr. Rt. %-NANANANANA-113.1%NANANA-
BVPS (₹ )8.38.28.221.121.121.721.521.320.72525.1
YoY Gr. Rt. %--0.6%-0.5%158.4%-0.1%2.9%-0.7%-1%-2.9%20.7%-
To view Net Profit/Total Funds (%) Colour Rating Guide click here
Net Profit/Total Funds (%)-2.9-0.5-0.5-3.1-0.22.5-0.3-0.6-2.2-0.60

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Net Interest IncomeNA-42.9%-63.9%-85%
Adj EPSNANANANA
BVPS13.1%3.5%5.1%20.7%
Share Price 3.8% -9.7% 17.9% 2.7%

Key Financial Ratios

RATIOS \ YEARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Margins
Net Profit Margin (%)00-9.8-261.3-0.11-0.2-0.8-4.4-62.4
Performance Ratios To view Performance Ratios Colour Rating Guide click here
Return on Equity (%)-3-0.6-0.5-3.2-0.22.9-0.4-1-2.9-0.60.6

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 0.60%

Total Income has declined -21.24 CAGR in last 3 years

Net Profit has declined 0.00 CAGR in last 3 years

Total income growth is poor in last 4 quarters

Latest Financials - Prism Medico and Pharmacy Ltd.

Standalone Consolidated
TTM EPS (₹) 0.2 0.1
TTM Sales (₹ Cr.) 4.1 54.4
BVPS (₹.) 25.1 0
Reserves (₹ Cr.) 9 7
P/BV 1.08 0.00
PE 167.36 408.00
From the Market
52 Week Low / High (₹) 22.41 / 39.20
All Time Low / High (₹) 3.00 / 85.15
Market Cap (₹ Cr.) 16.4
Equity (₹ Cr.) 6.1
Face Value (₹) 10
Industry PE 44.8

Management X-Ray of Prism Medico:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Prism Medico

Adj EPS (Rs.)

Total Income (Cr.)

ROE (%)

BVPS (Rs.)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Income00.060.150.1520.9636.5226.8916.768.441.27
Interest Income000.090.0920.9636.3126.8916.768.441.27
Other Income 00.060.060.0700.220000
Expenditure 0.050.060.160.3820.9136.2326.9616.948.941.37
Interest Expense 0000000000
Operating Expenses 0.050.060.150.3820.9136.2326.9616.938.941.30
Provisions 00000.0100000.07
Exceptional Items 0000000000
Profit Before Tax -0.05-0.01-0.01-0.230.050.29-0.07-0.18-0.50-0.10
Taxes 00000.07-0.08-0.02-0.05-0.13-0.03
Profit After Tax -0.05-0.01-0.01-0.23-0.020.37-0.05-0.13-0.37-0.08
Adjusted EPS (₹)-0.3-0.10.0-0.40.00.6-0.1-0.2-0.6-0.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Equity Capital1.641.641.6312.8012.7813.1513.0612.9312.5515.16
Share Capital 1.991.991.996.066.066.066.066.066.066.06
Reserves -0.35-0.36-0.366.746.727.096.996.866.499.10
Minority Interest0000000000
Long Term Borrowings00000.070-0.01-0.06-0.19-0.21
Current Liabilities 0.020.050.230.250.093.828.538.620.020.23
Trade Payables000.08003.578.458.4400
Short term borrowings00.020.070000000
Other Liabilities0-0.02-0.1500-3.57-8.45-8.4400
Total Liabilities 1.661.681.8513.0512.9416.9721.5721.4812.3815.18

Assets

Non Current Asset 0.020.01010.1611.3610.092.011.990.050.04
Loan Asset 0000000000
Other Non Current Asset 0.020.01010.1611.3610.092.011.990.050.04
Current Asset 1.641.671.852.901.576.8919.5619.4912.3415.14
Current Investment0000000000
Other Current Asset1.641.671.852.901.576.8919.5619.4912.3415.14
Total Assets 1.661.681.8513.0512.9416.9721.5721.4812.3815.18

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity -0.040.010.05-0.820-1.23-4.36-0.05-2.382.95
Cash Flow From Investing Activity 0.0300.460.3001.254.360.022.35-2.91
Cash Flow From Financing Activity 00.020.051.3300.060000
Net Cash Flow 00.020.560.8100.08-0.01-0.03-0.030.04
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Operational & Financial Ratios

EPS (₹)00000100-10
DPS (₹)0000000000
BVPS (₹)88821212222212125

Performance Ratios

ROA (%)-2.9-0.5-0.5-3.1-0.22.5-0.3-0.6-2.2-0.6
ROE (%)-3.0-0.6-0.5-3.2-0.22.9-0.4-1.0-2.9-0.6
ROCE (%)-2.9-0.6-0.5-3.10.42.3-0.5-1.4-3.9-0.7

Valuation Parameters

Price/Book(x)2.02.20.01.81.11.70.60.60.41.1

Prism Medico and Pharmacy Ltd Stock News

Prism Medico and Pharmacy Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Prism Medico on 19-Mar-2024 16:40 is ₹25.56.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 19-Mar-2024 16:40 the market cap of Prism Medico stood at ₹16.40.
The latest P/E ratio of Prism Medico as of 19-Mar-2024 16:40 is 167.4.
The latest P/B ratio of Prism Medico as of 19-Mar-2024 16:40 is 1.08.
The 52-week high of Prism Medico is ₹39.20 and the 52-week low is ₹22.41.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Prism Medico is ₹4.05 ( Cr.) .

About Prism Medico and Pharmacy Ltd

Woolite Mercantile Company Ltd.(WMCL) was incorporated on February 21, 1985 with the Registrar of Companies, Maharashtra, Mumbai, as a public limited xompany and obtained the certificate of commencement of business on March 8,1985.

Business area of the company:

The main object of the company was to carry on the trading in goods and commodities.. During the year ended March 31, 2008 the company earned Interest Income from loans and advances given and is presently engaged in the investing in shares and other securities and other financing activities.

2005-2006 During the financial year 2005-06, the income from share trading, mutual fund trading, mutual fund brokerage, etc increased due to better market conditions. So total income from operations during the financial year increased from Rs.0.94 lakh during the previous year to Rs.4.52 lakh. However, as the company sold its major investment in the financial year 2004-05 itself, its other income reduced from Rs.24.47 lakh to Rs.4.88 lakh. As a result the total income during the year reduced from Rs.27.42 lakh to Rs.9.40 lakh. Due to reduction in the expenses the net profit increased from Rs.1.07 lakh to Rs.4.09 lakh during the year.

2006-2007 During the financial year 2006-07, the company restricted its activities and did not carry any share trading activities. It carried on only mutual fund trading. So the total income & net profit during the year reduced to Rs.2.92 lakh & Rs.0.62 lakh respectively in comparison to previous year figures of Rs.9.40 lakh & Rs.4.09 lakh respectively.

2007-2008 In the financial year 2007-2008 the only income was interest from advances given, since the advances given was higher during the current year in comparison to previous year, hence the total income during the year increased to Rs.3.09 lakh in comparison to Rs.2.92 lakh during the previous year. However, as the expenses in the current year was also lower as compared to previous year as there were no business activities in the company, net profit during the year increased slightly to Rs.0.89 lakh from Rs.0.62 lakh during the previous year.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.